IL4 and diffuse large B-cell lymphoma: In diffuse large B-cell lymphoma (DLBCL), PARP14 regulated the IL-4-STAT6 signaling pathway, enhanced the expression of several downstream genes, and enabled DLBCL tumor cell survival [31].